A carregar...
Considerations for interactions of drugs used for the treatment of COVID-19 with anti-cancer treatments
SARS-CoV2 infection is an emerging issue worldwide. Cancer patient are at increased risk of infection compared to general population. On the other hand, these patients are at major risk of drug interactions caused by renal and hepatic impairment background. Because of the long-term use of chemothera...
Na minha lista:
| Publicado no: | Crit Rev Oncol Hematol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier B.V.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7217119/ https://ncbi.nlm.nih.gov/pubmed/32460133 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.critrevonc.2020.102982 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|